Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 21]
PHARMAC agrees funding for brain tumour treatment
Monday, 3 April 2006, 2:09 pm | PHARMAC
A new treatment for people with an aggressive form of brain tumour is to become fully subsidised from 1 May 2006. More >>
PHARMAC welcomes Medsafe approval of Herceptin
Thursday, 23 March 2006, 2:33 pm | PHARMAC
Medsafe’s decision to provisionally approve the wider use of the breast cancer drug Herceptin is welcomed and will enable PHARMAC to progress its assessment further, says PHARMAC spokeswoman Dr Dilky Rasiah. More >>
PHARMAC releases Australia vs NZ comparison
Monday, 20 March 2006, 3:52 pm | PHARMAC
PHARMAC has released its data on comparisons between medicines subsidised in New Zealand and Australia. More >>
PHARMAC, Schering-Plough reach agreement
Thursday, 2 March 2006, 2:15 pm | PHARMAC
PHARMAC and Schering-Plough have reached a provisional agreement for funding of the brain tumour treatment temozolomide (Temodal). More >>
New treatments subsidised for acne, pain
Tuesday, 28 February 2006, 4:46 pm | PHARMAC
A new anti-acne cream is one of two new skin creams to be fully subsidised from 1 March. More >>
Drug company survey shows doctors rate PHARMAC
Tuesday, 21 February 2006, 5:08 pm | PHARMAC
A drug company-backed survey issued today shows many doctors have a positive view of PHARMAC's overall performance. More >>
Doctors want increased funding for medicines
Tuesday, 21 February 2006, 10:25 am | PHARMAC
An overwhelming majority of general practitioners and specialists want Pharmac to be reviewed and believe increased funding of medicines should be a high priority for the Government, according to a UMR Research survey released today. More >>
PTAC has first view of trastuzumab (herceptin)
Thursday, 16 February 2006, 12:26 am | PHARMAC
The Pharmacology and Therapeutics Advisory Committee (PTAC) today examined evidence to support an application to fund trastuzumab (Herceptin) for early breast cancer. More >>
Medsafe, PHARMAC With Different Roles In Medicine
Tuesday, 14 February 2006, 5:53 pm | PHARMAC
New Zealand has two agencies that assess medicines – Medsafe, the regulator, and PHARMAC, the funder. Both have separate and distinct roles and are independent of each other. More >>
PHARMAC invests $103 million in NZers’ health
Monday, 9 January 2006, 3:41 pm | PHARMAC
An extra $103 million is being invested in New Zealanders’ health over the next five years as a result of recent pharmaceutical funding decisions. PHARMAC Chief Executive Wayne McNee says the current financial year, which began on 1 July, has seen a continued ... More >>
Independent report vindicates Salamol decision
Thursday, 5 January 2006, 5:08 pm | PHARMAC
A report by Government medicines assessment agency Medsafe has confirmed that the Salamol brand of salbutamol asthma inhalers is safe and effective. More >>
Tender marks 10th anniversary
Wednesday, 4 January 2006, 2:04 pm | PHARMAC
PHARMAC is marking the 10th anniversary of its annual tender, which has been issued to pharmaceutical suppliers. More >>
Goserelin to remain available to NZers
Monday, 19 December 2005, 5:02 pm | PHARMAC
People with prostate cancer and breast cancer will continue to have fully funded access to the hormonal treatment goserelin (Zoladex) following an agreement between Government drug-funding agency PHARMAC and pharmaceutical company AstraZeneca. More >>
Hospital cancer drug funding approved
Monday, 19 December 2005, 10:46 am | PHARMAC
A hospital drug for colorectal cancer will gain wider usage following a decision by Government drug-funder PHARMAC and District Health Boards. More >>
Transparency call in British parliamentary inquiry
Wednesday, 7 December 2005, 10:22 am | PHARMAC
A British Parliamentary Committee has called for more openness and transparency from groups and agencies linked to the pharmaceutical industry. Former British Medical Journal editor Dr Richard Smith, writing in PHARMAC’s 2005 Annual Review, says the ... More >>
PHARMAC heart campaign continues to grow
Wednesday, 7 December 2005, 9:28 am | PHARMAC
The One Heart Many Lives campaign is continuing to grow and produce positive results, says PHARMAC Medical Director Dr Peter Moodie. More >>
Cancer drug funding a challenge – PHARMAC
Tuesday, 6 December 2005, 10:18 am | PHARMAC
Planning and budgeting for new cancer treatments provides one of PHARMAC’s biggest challenges for the future, says PHARMAC’s Medical Director Dr Peter Moodie. More >>
PHO impact seen in subsidised prescribing jump
Tuesday, 6 December 2005, 10:17 am | PHARMAC
The number of prescriptions subsidised by the Government has climbed to an all-time high, figures from drug-funding agency PHARMAC show. More >>
Spending on target, patient numbers growing
Tuesday, 6 December 2005, 8:58 am | PHARMAC
Nearly 7000 people were treated with newly-subsidised medicines as a result of funding decisions made in the 2004-2005 year, figures released today by Government drug funder PHARMAC show. More >>
SSRI prescribing up 9.7 percent despite warnings
Tuesday, 6 December 2005, 12:39 am | PHARMAC
Prescribing of new-generation antidepressants continues to grow strongly, figures issued today by government drug funder PHARMAC show. More >>
